Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Propofol and Remifentanil in Obese vs Non-Obese Patients
NCT04492813Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2018
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of propofol and remifentanil in general anesthesia (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoints: Plasma concentration of Propofol and Plasma concentration of Remifentanil. Started Dec 2018; status: completed.
02
Drugs
propofolremifentanil
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT04492813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04492813.